Document is current
Any future updates will be listed below
-
Authors
Vila-Castelar, Clara https://orcid.org/0000-0002-8779-1487
Akinci, Muge
Palpatzis, Eleni https://orcid.org/0000-0001-8478-273X
Aguilar-Dominguez, Pablo
Operto, Gregory
Kollmorgen, Gwendlyn
Quijano-Rubio, Clara https://orcid.org/0000-0001-9050-3282
Blennow, Kaj https://orcid.org/0000-0002-1890-4193
Zetterberg, Henrik https://orcid.org/0000-0003-3930-4354
Falcon, Carles https://orcid.org/0000-0001-5564-2025
Fauria, Karine
Gispert, Juan Domingo https://orcid.org/0000-0002-6155-0642
Grau-Rivera, Oriol
Suárez-Calvet, Marc https://orcid.org/0000-0002-2993-569X
Arenaza-Urquijo, Eider M. https://orcid.org/0000-0001-7016-7576
,
Anastasi, Federica
Beteta, Annabella
Brugulat-Serrat, Anna
Cacciaglia, Raffaele
Cumplido-Mayoral, Irene
Cañas, Alba
del Campo, Marta
Deulofeu, Carme
Dominguez, Ruth
Emilio, Maria
Fernández-Arcos, Ana
Fuentes, Sherezade
Genius, Patricia
González-Escalante, Armand
Hernández, Laura
Hernández-Villamizar, Felipe
Huguet, Jordi
López-Martos, David
Lugo, Ferran
Marne, Paula
Menchón, Tania
Minguillon, Carolina
Ortiz, Paula
Pelkmans, Wiesje
Polo, Albina
Pradas, Sandra
Rodríguez-Fernández, Blanca
Sánchez-Benavides, Gonzalo
Shekari, Mahnaz
Soteras, Anna
Stankeviciute, Laura
Vilanova, Marc
Vilor-Tejedor, Natalia
- License Information
-
More Information
Article History
Received: 19 January 2024
Revised: 3 September 2024
Accepted: 6 September 2024
First Online: 9 October 2024
Competing interests
: CV-C, MA, EP, PA-D, GO, KB, JD-G, CF, KFC and EMAU report no conflict of interest. HZ has served at scientific advisory boards and/or as a consultant for Abbvie, Acumen, Alector, Alzinova, ALZPath, Annexon, Apellis, Artery Therapeutics, AZTherapies, Cognito Therapeutics, CogRx, Denali, Eisai, Merry Life, Nervgen, Novo Nordisk, Optoceutics, Passage Bio, Pinteon Therapeutics, Prothena, Red Abbey Labs, reMYND, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Alzecure, Biogen, Cellectricon, Fujirebio, Lilly, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program (outside submitted work). OG-R has given lectures in symposia sponsored by Roche Diagnostics, and receives support for research (to the institution) from F- Hoffmann La Roche. GK is a full‑time employee of Roche Diagnostics GmbH. CQ-R is a full‑time employee of Roche Diagnostics International Ltd. MS-C has given lectures in symposia sponsored by Roche Diagnostics, S.L.U, Roche Farma, S.A, Eli Lilly and Amirall, he has served as a consultant and at advisory boards for Roche Diagnostics International Ltd and Grifols S.L. He was granted with a project funded by Roche Diagnostics International Ltd. All payments were made to the institution (BBRC). He received in-kind support for research (to the institution) from Roche Diagnostics International Ltd, Avid Radiopharmaceuticals, Inc., Eli Lilly and Janssen Research & Development.
